Revvity Inc vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.51. The key difference: Revvity Inc pays a 0.26% dividend while iShares Broad USD Investment Grade Corporate Bond pays none, and Revvity Inc is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.
| RVTY | USIG | |
|---|---|---|
Market Cap | $11.87B | — |
Sector | Technology | Fixed Income |
52-Week High | $117.75 | $52.69 |
52-Week Low | $82.26 | $50.50 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | — |
Trailing returns across standard periods
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →